Health Sciences

The cancer fighters: John Glick and a legacy of a half century in oncology

A major figure in the fight against cancer, John Glick reflects on his career after decades of working with the Perelman School of Medicine and as director of Penn’s National Cancer Institute for more than 20 years, treating thousands of patients during his tenure.

From Penn Medicine News

Developing new technologies to solve the mysteries of the brain

The Perelman School of Medicine’s Flavia Vitale is using her background in biomedical and chemical engineering to develop cutting edge materials and devices that will help clinicians diagnose and treat brain disorders.

From Penn Medicine News

Coding the emotions that anti-tobacco ads evoke

Sophomore Oulaya Louaddi and junior Gabriela Montes de Oca interned this summer with Annenberg’s Andy Tan, helping the research team design and test culturally appropriate anti-smoking campaigns for young women who identify as sexual minorities.

Michele W. Berger



In the News


The New York Times

Waiting on U.S. mandate, some nursing homes are slow to vaccinate staff

PIK Professor Ezekiel Emanuel said lower COVID-19 vaccination rates lead to more infections. “We should be clear that mandates have been working and have been working in every industry that has tried them,” he said.

FULL STORY →



Scientific American

Four success stories in gene therapy

Jean Bennett and Albert Maguire of the Perelman School of Medicine developed a gene therapy to treat blindness in patients with retinal dystrophy caused by mutations in the RPE65 gene. “These people can now do things they never could have dreamed of doing, and they’re more independent and enjoying life,” said Bennett.

FULL STORY →



ABC News

Why breakthrough COVID deaths can be misunderstood

Edward Stadtmauer of the Perelman School of Medicine advised cancer patients to get vaccinated against COVID-19. “If you have abnormal plasma cells to begin with or are getting therapy that might suppress or damage plasma cells, you can see why that this group of patients may have the most difficulty responding to a COVID infection and responding to vaccines,” he said. “If there is any group of patients who should be vaccinated and get a booster, it is this group of patients.”

FULL STORY →



ABC News

Why COVID boosters weren't tweaked to better match variants

John Wherry of the Perelman School of Medicine said there’s no guarantee that a booster shot retooled to target the delta variant would work better than a general COVID-19 vaccine booster.

FULL STORY →



The New York Times

Data from federal scientists raise questions about J.&J. booster shots

Scott Hensley of the Perelman School of Medicine is quoted on which vaccines should offer an mRNA booster and how much data the F.D.A. needs before making that recommendation.

FULL STORY →